Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.7%

1 terminated/withdrawn out of 58 trials

Success Rate

90.9%

+4.4% vs industry average

Late-Stage Pipeline

9%

5 trials in Phase 3/4

Results Transparency

0%

0 of 10 completed trials have results

Key Signals

13 recruiting

Enrollment Performance

Analytics

N/A
34(77.3%)
Phase 4
4(9.1%)
Phase 2
3(6.8%)
Phase 1
2(4.5%)
Phase 3
1(2.3%)
44Total
N/A(34)
Phase 4(4)
Phase 2(3)
Phase 1(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (58)

Showing 20 of 58 trials
NCT06271200Not ApplicableRecruiting

Strategic Lifestyle Intervention for Metabolic Syndrome (SLIM-MET)

Role: collaborator

NCT06968871Not ApplicableRecruiting

Ameliorated Pap Tests and Cervical Cancer Screening Participation

Role: collaborator

NCT06678724Recruiting

Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA Chip

Role: collaborator

NCT04496882Phase 4Active Not Recruiting

Chronic Hepatitis b Patients Switch to tAf After Discontinuation of Nucleoside Analogue

Role: collaborator

NCT06620328Not ApplicableRecruiting

Safety and Efficacy of Mechanical Versus Electrocautery Dilator for EUS-guided Biliary Drainage (MED-BD)

Role: collaborator

NCT07325318Not ApplicableCompleted

Shockwave Dose for Adhesive Capsulitis

Role: lead

NCT05979350Not ApplicableActive Not Recruiting

Metagenomic NGS for Diagnosis of Pneumonia

Role: collaborator

NCT06069141Not ApplicableRecruiting

Comparisons of Treatment Responses of Early Syphilis to Benzathine Penicillin G With or Without Doxycycline

Role: collaborator

NCT06103045Not ApplicableCompleted

The Effects of Unilateral and Bilateral Mirror Therapy on Upper Extremity Function of Stroke at Acute Stage.

Role: lead

NCT07091942Recruiting

Curative Therapy After Atezolizumab and Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma

Role: collaborator

NCT07039968Phase 2Recruiting

Standard Dose Versus High Dose Stereotactic Spine Radiosurgery for Metastatic Spinal Neoplasms

Role: collaborator

NCT07034859Phase 4Enrolling By Invitation

Cabergoline in the Management of Nonfunctioning Pituitary Adenoma

Role: collaborator

NCT07012200Not ApplicableTerminated

Effect of Immersive Interactive Nursing Guidance on Anxiety, Cognition, and Self-efficacy in CHD Patients Undergoing Cardiac Catheterization

Role: lead

NCT06772194Recruiting

Taiwan Post-Stroke Disability Study

Role: collaborator

NCT06768268Phase 1Enrolling By Invitation

A Dose-Image Optimization Trial Evaluating Mannitol and Voluven as Adjuncts for Indocyanine Green

Role: collaborator

NCT06900725Phase 2Not Yet Recruiting

Low Dose Edoxaban in Elderly Patients With AF and a History of Stroke

Role: collaborator

NCT06878079Not Yet Recruiting

ERAS and Postoperative Recovery in Gynecologic Patients: A QoR-15 Study

Role: collaborator

NCT05878223Not ApplicableRecruiting

Comparing ESWT Doses for Post-Stroke Ankle Spasticity Treatment

Role: lead

NCT06503445Not ApplicableCompleted

The Impact of Video-based Cardiac Rehabilitation Education in Patients With CIEDs- a Randomized Controlled Trial

Role: lead

NCT05712434Not ApplicableCompleted

Chlorhexidine to Prevent Catheter-related Urinary Tract Infection

Role: collaborator